Daxor Corp also files under EDXR; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Jefferies John | Chief Medical Officer | Grant(A) | 2K | — | $0 |
| Jun 23, 2026 | DesRosiers Caleb | Director | Grant(A) | 3K | — | $0 |
| Jun 23, 2026 | Goudie Joy S. | Director | Grant(A) | 3K | — | $0 |
| Jun 23, 2026 | Cremisi Henry D. | Director | Grant(A) | 3K | — | $0 |
| Jun 23, 2026 | Michel Robert J | Chief Financial Officer | Grant(A) | 12K | — | $0 |
| Jun 23, 2026 | Feuer Edward | Director | Grant(A) | 3K | — | $0 |
| Jun 23, 2026 | Feldschuh Jonathan Adam | Chief Scientific Officer, Director | Grant(A) | 25K | — | $0 |
| Jun 23, 2026 | Feldschuh Michael Richard | Chief Executive Officer, Director | Grant(A) | 30K | — | $0 |
| Apr 8, 2026 | Feldschuh Michael Richard | Chief Executive Officer, Director | Buy(P) | 1K | $9.07 | $9K |
| Mar 31, 2026 | Michel Robert J | Chief Financial Officer | Buy(P) | 1K | $9.90 | $10K |
| Mar 20, 2026 | Jefferies John | Chief Medical Officer | Buy(P) | 2K | — | $0 |
| Mar 20, 2026 | Jefferies John | Chief Medical Officer | Buy(P) | 4K | — | $0 |
| Dec 9, 2025 | Michel Robert J | Chief Financial Officer | Buy(P) | 3K | — | $0 |
| Dec 9, 2025 | Feldschuh Jonathan Adam | Chief Scientific Officer, Director | Buy(P) | 18K | — | $0 |
| Nov 12, 2025 | Jefferies John | Chief Medical Officer | Buy(P) | 2K | — | $0 |
| Jun 24, 2025 | Goudie Joy S. | Director | Grant(A) | 3K | — | $0 |
| Jun 24, 2025 | Feuer Edward | Director | Grant(A) | 3K | — | $0 |
| Jun 24, 2025 | DesRosiers Caleb | Director | Grant(A) | 3K | — | $0 |
| Jun 24, 2025 | Cremisi Henry D. | Director | Grant(A) | 3K | — | $0 |
| Apr 4, 2025 | Feldschuh Michael Richard | Chief Executive Officer, Director | Buy(P) | 2K | $7.89 | $16K |
| Mar 10, 2025 | Michel Robert J | Chief Financial Officer | Buy(P) | 1K | $8.00 | $8K |
| Dec 6, 2024 | Feldschuh Michael Richard | Chief Executive Officer, Director | Buy(P) | 45K | — | $0 |
| Dec 6, 2024 | Feldschuh Jonathan Adam | Chief Scientific Officer, Director | Buy(P) | 32K | — | $0 |
| Jul 15, 2024 | DesRosiers Caleb | Director | Grant(A) | 3K | — | $0 |
| Jul 15, 2024 | Feuer Edward | Director | Grant(A) | 3K | — | $0 |
| Jul 15, 2024 | Goudie Joy S. | Director | Grant(A) | 3K | — | $0 |
| Jul 15, 2024 | Cremisi Henry D. | Director | Grant(A) | 3K | — | $0 |
| Mar 27, 2024 | Michel Robert J | Chief Financial Officer | Buy(P) | 750 | $8.70 | $7K |
| Mar 26, 2024 | Feldschuh Michael Richard | Chief Executive Office, Director | Buy(P) | 1K | $8.13 | $8K |
| Mar 19, 2024 | Feldschuh Michael Richard | Chief Executive Officer, Director | Buy(P) | 647 | $8.15 | $5K |
| Mar 10, 2024 | Feldschuh Michael Richard | Chief Executive Officer, Director | Buy(P) | 1K | $7.72 | $12K |
| Mar 4, 2024 | Feuer Edward | Director | Buy(P) | 1K | $7.21 | $7K |
| Dec 6, 2023 | Michel Robert J | Chief Financial Officer | Buy(P) | 120 | $7.75 | $930 |
| Dec 1, 2023 | Feldschuh Michael Richard | Chief Executive Officer, Director | Buy(P) | 800 | $7.80 | $6K |
| Dec 1, 2023 | Michel Robert J | Chief Financial Officer | Buy(P) | 180 | $7.75 | $1K |
| Nov 24, 2023 | Michel Robert J | Chief Financial Officer | Buy(P) | 500 | $7.94 | $4K |
| Nov 21, 2023 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 84 | $7.65 | $643 |
| Nov 10, 2023 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 1K | $7.83 | $8K |
| Nov 9, 2023 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 401 | $7.85 | $3K |
| Oct 31, 2023 | Michel Robert J | Chief Financial Officer | Grant(A) | 5K | — | $0 |
| Oct 31, 2023 | Michel Robert J | Chief Financial Officer | Grant(A) | 2K | — | $0 |
| Oct 13, 2023 | Michel Robert J | Chief Financial Officer | Buy(P) | 500 | $9.02 | $5K |
| Sep 18, 2023 | Estate of Joseph Feldschuh | 10% Owner | Gift(G) | 25K | — | $0 |
| Jul 11, 2023 | DesRosiers Caleb | Director | Grant(A) | 3K | — | $0 |
| Jul 11, 2023 | Goudie Joy S. | Director | Grant(A) | 3K | — | $0 |
| Jul 11, 2023 | Michel Robert J | Chief Financial Officer | Grant(A) | 14K | — | $0 |
| Jul 11, 2023 | Feldschuh Michael Richard | Chairman, President & CEO, Director | Grant(A) | 30K | — | $0 |
| Jul 11, 2023 | Feldschuh Jonathan Adam | Chief Scientific Officer, Director | Grant(A) | 25K | — | $0 |
| Jul 11, 2023 | Lombard James A | Director | Grant(A) | 3K | — | $0 |
| Jul 11, 2023 | Cremisi Henry D. | Director | Grant(A) | 3K | — | $0 |
| Jul 11, 2023 | Feuer Edward | Director | Grant(A) | 3K | — | $0 |
| May 24, 2023 | Feldschuh Michael Richard | CEO & President | Buy(P) | 2K | $9.75 | $20K |
| May 24, 2023 | Goudie Joy S. | Director | Buy(P) | 300 | $9.75 | $3K |
| Mar 27, 2023 | Michel Robert J | Chief Financial Officer | Buy(P) | 5K | — | $0 |
| Nov 18, 2022 | Michel Robert J | Chief Financial Officer | Buy(P) | 1K | $10.00 | $10K |
| Nov 17, 2022 | DesRosiers Caleb | Director | Buy(P) | 3K | $9.50 | $30K |
| Jun 23, 2022 | Feuer Edward | Director | Grant(A) | 2K | — | $0 |
| Jun 23, 2022 | DesRosiers Caleb | Director | Grant(A) | 4K | — | $0 |
| Jun 23, 2022 | Lombard James A | Director | Grant(A) | 2K | — | $0 |
| Jun 23, 2022 | Cremisi Henry D. | Director | Grant(A) | 2K | — | $0 |
| Jun 23, 2022 | Goudie Joy S. | Director | Grant(A) | 2K | — | $0 |
| Jun 24, 2021 | Cremisi Henry D. | Director | Grant(A) | 2K | — | $0 |
| Jun 24, 2021 | Goudie Joy S. | Director | Grant(A) | 2K | — | $0 |
| Jun 24, 2021 | Feuer Edward | Director | Grant(A) | 2K | — | $0 |
| Jun 24, 2021 | Lombard James A | Director | Grant(A) | 2K | — | $0 |
| Jun 10, 2021 | Michel Robert J | CHIEF FINANCIAL OFFICER | Grant(A) | 2K | — | $0 |
| Apr 19, 2021 | Michel Robert J | CHIEF FINANCIAL OFFICER | Buy(P) | 1K | $10.25 | $10K |
| Apr 16, 2021 | Feldschuh Michael Richard | CEO & President | Buy(P) | 4K | $10.33 | $43K |
| Jul 22, 2020 | Estate of Joseph Feldschuh | 10% Owner | Disposed to issuer(D) | 225K | $20.00 | $4.5M |
| Jul 22, 2020 | Feuer Edward | Director | Disposed to issuer(D) | 2K | $19.21 | $29K |
| Jun 29, 2020 | Goudie Joy S. | Director | Grant(A) | 2K | — | $0 |
| Jun 25, 2020 | Cremisi Henry D. | Director | Grant(A) | 18K | — | $0 |
| Jun 25, 2020 | Cremisi Henry D. | Director | Grant(A) | 2K | — | $0 |
| Jun 25, 2020 | Feldschuh Michael Richard | CEO & President, Director | Grant(A) | 25K | — | $0 |
| Jun 25, 2020 | Michel Robert J | CHIEF FINANCIAL OFFICER | Grant(A) | 10K | — | $0 |
| Jun 25, 2020 | Feldschuh Jonathan Adam | Chief Scientific Officer, Director | Grant(A) | 20K | — | $0 |
| Jun 25, 2020 | Feuer Edward | Director | Grant(A) | 2K | — | $0 |
| Jun 25, 2020 | Lombard James A | Director | Grant(A) | 2K | — | $0 |
| Jun 25, 2020 | Wolpoff Martin S | Director | Grant(A) | 2K | — | $0 |
| Jun 25, 2020 | Saxe Bernhard | Director | Grant(A) | 2K | — | $0 |
| Mar 22, 2019 | Michel Robert J | CHIEF FINANCIAL OFFICER | Buy(P) | 750 | $13.02 | $10K |
| Mar 21, 2019 | Feldschuh Michael Richard | CEO & President | Buy(P) | 200 | $12.20 | $2K |
| Mar 21, 2019 | Feldschuh Michael Richard | CEO & President | Buy(P) | 600 | $12.36 | $7K |
| Mar 21, 2019 | Feldschuh Michael Richard | CEO & President | Buy(P) | 400 | $12.40 | $5K |
| Nov 7, 2018 | Michel Robert J | CHIEF FINANCIAL OFFICER | Buy(P) | 3K | $7.42 | $19K |
| Jul 31, 2018 | Thompson Soren | VP, Business Development | Sell(P) | 1K | $5.50 | $6K |
| Jul 13, 2018 | Feuer Edward | Director | Buy(P) | 2K | $6.18 | $9K |
| Mar 15, 2018 | Feldschuh Jonathan Adam | Director | Sell(S) | 19K | $18.63 | $358K |
| Mar 15, 2018 | Feldschuh Michael Richard | President, Director | Sell(S) | 21K | $16.40 | $341K |
| Mar 15, 2018 | Thompson Soren | Vice President | Sell(S) | 3K | $19.54 | $58K |
| Mar 9, 2018 | Feldschuh Joseph | 10% Owner | Sell(S) | 37K | $6.44 | $238K |
| Oct 17, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 2 | $4.66 | $9 |
| Oct 16, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 148 | $4.95 | $733 |
| Oct 13, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 3 | $4.95 | $15 |
| Oct 12, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 49 | $4.95 | $243 |
| Sep 5, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 100 | $5.40 | $540 |
| Aug 25, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 200 | $5.56 | $1K |
| Aug 24, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 200 | $5.63 | $1K |
| Jun 28, 2017 | Thompson Soren | VP Business Development | Buy(P) | 500 | $6.50 | $3K |
| May 19, 2017 | Feldschuh Michael Richard | President & CEO, Director | Buy(P) | 212 | $6.72 | $1K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Daxor Corp, SEC CIK 0000027367. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under DXR and shows every filing by that issuer (also filed as EDXR).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for DXR